CAXTON CORP - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 193 filers reported holding CARDLYTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of CARDLYTICS INC
ValueSharesWeighting
Q1 2022$470,000
-18.7%
8,543
-2.3%
0.58%
+23.7%
Q4 2021$578,000
+1.2%
8,740
+28.5%
0.47%
+1.9%
Q3 2021$571,000
-33.9%
6,801
-0.1%
0.46%
-21.8%
Q2 2021$864,000
+107.7%
6,805
+79.4%
0.59%
+119.3%
Q1 2021$416,000
+1.5%
3,793
+32.2%
0.27%
+5.5%
Q4 2020$410,000
+16.5%
2,869
-48.7%
0.26%
-24.5%
Q4 2019$352,0005,5940.34%
Other shareholders
CARDLYTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders